AWM
CYTK icon

Avior Wealth Management’s Cytokinetics CYTK Stock Holding History

Avior Wealth Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,718
Closed -$175K – 1113
2024
Q4 		$175K Sell
3,718
-281
-7% -$14.6K 0.01% 744
2024
Q3 		$211K Buy
3,999
+1,454
+57% +$81K 0.01% 681
2024
Q2 		$138K Sell
2,545
-184
-7% -$11.1K 0.01% 777
2024
Q1 		$191K Buy
+2,729
New +$211K 0.01% 721
2023
Q4 		– Sell
-330
Closed -$11.9K – 1548
2023
Q3 		$9.72K Hold
330
– – ﹤0.01% 1049
2023
Q2 		$10.8K Hold
330
– – ﹤0.01% 1016
2023
Q1 		$11.6K Hold
330
– – ﹤0.01% 1030
2022
Q4 		$15.1K Hold
330
– – ﹤0.01% 795
2022
Q3 		$15K Hold
330
– – ﹤0.01% 784
2022
Q2 		$12K Hold
330
– – ﹤0.01% 742
2022
Q1 		$12K Hold
330
– – ﹤0.01% 798
2021
Q4 		$15K Buy
+330
New +$12.7K ﹤0.01% 751
2021
Q3 		– Sell
-100
Closed -$1K – 1076
2021
Q2 		$1K Hold
100
– – ﹤0.01% 946
2021
Q1 		$2K Buy
+100
New +$2.13K ﹤0.01% 903
2018
Q2 		– Sell
-175
Closed -$1K – 793
2018
Q1 		$1K Hold
175
– – ﹤0.01% 718
2017
Q4 		$1K Buy
175
+30
+21% +$341 ﹤0.01% 721
2017
Q3 		$3K Sell
145
-30
-17% -$410 ﹤0.01% 417
2017
Q2 		$2K Buy
+175
New +$2.43K ﹤0.01% 408
2014
Q2 		– Sell
-260
Closed -$2K – 328
2014
Q1 		$2K Buy
+260
New +$2.35K ﹤0.01% 310

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Avior Wealth Management's CYTK Position: Q1 2025 in Review

Avior Wealth Management sold out of Cytokinetics (CYTK) in Q1 2025, closing a stake of 3,718 shares — an estimated $175K sold.

Avior Wealth Management first reported a position in CYTK in Q1 2014 and held it in 19 quarters. The position peaked at $211K in Q3 2024. 355 funds tracked by Wall St. Rank hold CYTK as of Q1 2025.

  • Avior Wealth Management reported no remaining Cytokinetics position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 3,718 Cytokinetics shares in Q1 2025, an estimated $175K.
  • Avior Wealth Management first reported a position in Cytokinetics in Q1 2014 and held it in 19 quarters.
  • Avior Wealth Management's Cytokinetics position peaked at $211K in Q3 2024.
  • 355 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.